CAS 1247018-19-4

Formula: C26H31FN6O2S

InChI: InChI=1S/C26H31FN6O2S/c1-31-20-29-17-23(31)19-32(25-11-10-22(16-28)15-24(25)27)13-14-33(18-21-7-3-2-4-8-21)36(34,35)26-9-5-6-12-30-26/h5-6,9-12,15,17,20-21H,2-4,7-8,13-14,18-19H2,1H3

InChI key: BXNRVJLIEMQDOL-UHFFFAOYSA-N

SMILES: CN1C=NC=C1CN(CCN(CC2CCCCC2)S(=O)(=O)C3=CC=CC=N3)C4=C(C=C(C=C4)C#N)F

FGTI-2734

CAS: 1247018-19-4

FGTI-2734

Formula: C₂₆H₃₁FN₆O₂S

Purity: ≥98%

Molecular weight: 510.63

Ref: 54-BUP05267

FGTI-2734

CAS: 1247018-19-4

Purity: 98%

Ref: IN-DA01V6M9

FGTI-2734

CAS: 1247018-19-4

N-(2-((4-Cyano-2-fluorophenyl)((1-methyl-1H-imidazol-5-yl)methyl)amino)ethyl)-N-(cyclohexylmethyl)pyridine-2-sulfonamide

Formula: C₂₆H₃₁FN₆O₂S

Purity: 98+%

Molecular weight: 510.63

Ref: IN-DG01135769

FGTI-2734

CAS: 1247018-19-4

Please enquire for more information about FGTI-2734 including the price, delivery time and more detailed product information at the technical inquiry form on this page

Formula: C₂₆H₃₁FN₆O₂S

Purity: Min. 95%

Molecular weight: 510.6 g/mol

Ref: 3D-XZB01819

FGTI-2734

CAS: 1247018-19-4

FGTI-2734, a dual FT/GGT-1 inhibitor (IC50: 250/520 nM), blocks KRAS membrane binding and curbs KRAS-driven pancreatic cancer.

Formula: C₂₆H₃₁FN₆O₂S

Purity: 99.69%

Color and Shape: Solid

Molecular weight: 510.63

Ref: TM-T11282